Abstract:Objective To investigate the change of islet α-cell and β-cell function at different levels of HbA1C in patients with type 2 diabetes mellitus.Methods A total of 288 cases of type 2 diabetic patients were divided into four groups according to their HbA1C levels:HbA1C ≤ 7.0％ (Group A),7.0％＜HbA1CC ≤ 9.0％ (Group B),9.0％＜HbA1C ≤ 11.0％ (Group C),and HbA1C＞11.0％ (Group D).Oral glucose tolerance test,insulin releasing test,and glucagon releasing test were performed to observe the differences in glucagon,glucagon/insulin,early insulin secretion index (△I30/△G30),and the second-phase insulin secretion index [using area under curve of insulin(AUC1)] among the four groups,and a correlation analysis was performed between glucagon and other indicators.Result (1) Glucagon,glucagon/insulin,and area under curve of glucagon increased significantly with the increase of HbA1C(all P＜0.05).(2) Compared with group A,homeostasis model assessment for insulin resistance (HOMA-IR) in group B,C,and D were significantly higher(P＜0.05),insulin sensitivity index,homeostasis model assessment for β cell function (HOMA-β),△I30/△G30,the AUC1 were significantly lower(all P＜0.05).Compared with group A,△I30/△G30 in group B and C dropped about 50％ (P＜0.05),and △I30/△G30 in group D decreased 90％ (P＜0.05).(3) Person correlation analysis showed that glucagon had a negative correlation with △I30/△G30,HOMA-β,body mass index,insulin sensitivity index,AUC1 (all P＜0.05),and a positive correlation with fasting plasma glucose,area under curve of glucose,HOMA-IR,HbA1C,course of diabetes (all P＜0.05).Conclusions Abnormal function of islet α-cell and β-cell exist in patients with type 2 diabetes,especially in those with higher levels of HbA1C,indicating that regulation of glucagon will make the blood glucose target be reached more easily.

Progress in the measurement and evaluation of islet β cell mass

Progress of the Test and Assessment of Islet Β Cell Function

Beta-Cell Function in Chinese Youngsters with Type 1 Diabetes and Assessment of Surrogate Markers of Severe Insulin Deficiency

Improvement of massive human islet isolation techniques and their quality evaluation

Progress in Molecular Nuclear Medicine Imaging of Pancreatic Beta Cells

Imaging Beta-Cell Mass and Function in Situ and in Vivo

Dynamic Monitoring of Β-Cell Injury with Impedance and Rescue by Glucagon-Like Peptide-1

Quantification Ofβcell Mass Using18 F-FP-(+)-DTBZ, a Vesicular Monoamine Transporter Type 2 Radiotracer:A Longitudinal Study in Type 1 Diabetic Rats

Advances in radionuclide molecular imaging of pancreatic β-cells

Molecular Imaging of Β-Cells: Diabetes and Beyond

Assessment of Residual Beta-Cell Function Using the Glucagon Test in Type 2 Diabetic Patients

[Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].

To β-e or not to β-e replicating after 30: retrospective dating of human pancreatic islets

An Optical Method to Evaluate Both Mass and Functional Competence of Pancreatic Α- and Β-Cells.

Research Progress of Radionuclide Molecular Imaging in Pancreatic Beta Cells

Evaluation of islet α-cell and β-cell function at different levels of HbA1C in patients with type 2 diabetes mellitus

A Smartphone-Fluidic Digital Imaging Analysis System for Pancreatic Islet Mass Quantification

Changes of Islet Β-Cell Function in Patients with Normal Glucose Tolerance, Impaired Glucose Tolerance and Type 2 Diabetes

Research on application of C- peptide in the functional evaluation of pancreatic islet β cells

Systematic Review of Clinical Application Effect of Islet Allotransplantation for Type 1 Diabetes

Improvement of Massive Human Islet Isolation Techniques and the Evaluation of Isolated Human Islets